Early stage cost-effectiveness analysis of a BRCA1-like test to detect triple negative breast cancers responsive to high dose alkylating chemotherapy

Anna Miquel Cases, Lotte M.G. Steuten, Valesca P. Retèl, Wim H. van Harten

Research output: Contribution to journalArticleAcademicpeer-review

11 Citations (Scopus)
20 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Early stage cost-effectiveness analysis of a BRCA1-like test to detect triple negative breast cancers responsive to high dose alkylating chemotherapy'. Together they form a unique fingerprint.

Medicine and Dentistry